Topical delivery of retinyl ascorbate co-drug. 1. Synthesis, penetration into and permeation across human skin.
A novel synthetic technique was used to synthesise the co-drug retinyl ascorbate (RA-AsA) ester from all-trans-retinyl chloride (RA) and L-ascorbic acid (AsA) suspended in ethanol at low temperature. Its log P, solubility in a Me:PBS, 50/50 at pH 4.8 and degradation constant were determined. The flux and permeation coefficient were determined using heat separated human skin membrane, and skin penetration was determined by tape stripping using full thickness human. All experiments were performed in parallel with retinyl palmitate (Rol-Pal) and ascorbyl palmitate (AsA-Pal), which are used in commercial topical formulations. RA-AsA exhibited favourable log P (2.2), with stability much greater than RA and AsA, but similar stability to Rol-Pal and AsA-Pal. The flux of RA-AsA was lower than for Rol-Pal and AsA-Pal. RA-AsA also demonstrated higher skin retention than the other two esters, but delivered more RA and AsA to the viable epidermis than retinol from Rol-Pal and ascorbic acid from AsA-Pal. Overall, the data suggest the potential value of RA-AsA co-drug for the purpose of treating damage to skin resulting from UV-induced production of free radicals.
Abdulmajed
Kasem
K
Welsh School of Pharmacy, Cardiff University, Cardiff CF10 3XF, UK.
Heard
Charles M
CM
D000287:Administration, Topical; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology*; D014801:Vitamin A / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D014801:Vitamin A; D001205:Ascorbic Acid